Dr. Isabelle Gagnon is a board-certified Medical Oncologist associated with a major university teaching hospital in Montreal. With over 12 years of clinical experience, she specializes in precision oncology, focusing on how genomic profiling can guide targeted therapy and immunotherapy. She is actively involved in clinical trials and patient education regarding complex treatment pathways.
Dr. Isabelle Gagnon completed her medical degree and residency at the Université de Montréal, followed by a fellowship in Experimental Therapeutics at the Dana-Farber Cancer Institute. Upon returning to Quebec, she established herself as a leader in the field of precision medicine, specifically advocating for the use of advanced biomarkers to tailor cancer treatments. Her daily practice involves managing complex cases where standard chemotherapy has failed, transitioning patients to targeted immunotherapies that minimize systemic toxicity. Dr. Gagnon is deeply knowledgeable about the 'Patient d'exception' measure in Quebec, helping patients access unfunded drugs when necessary. She frequently publishes on the nuances of side effect management for new biological drugs, which often present differently than traditional chemotherapy symptoms. Beyond her clinical duties, she is dedicated to demystifying the 'black box' of genetic testing for patients, explaining clearly why certain tumors respond to specific inhibitors while others do not. Her goal is to ensure every patient understands the 'why' behind their treatment plan.